| Pharmaceutical Information |
| Drug Name |
Crofelemer |
| Drug ID |
BADD_D00536 |
| Description |
Crofelemer, previously known as the investigational drug SP-303, is a novel proanthocyanidin purified from the bark latex of the Amazonian Croton tree Croton lechleri. It is marketed under the brand name Fulyzaq and indicated for the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy. |
| Indications and Usage |
For the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy. |
| Marketing Status |
approved |
| ATC Code |
A07XA06 |
| DrugBank ID |
DB04941
|
| KEGG ID |
D03605
|
| MeSH ID |
C546704
|
| PubChem ID |
36511
|
| TTD Drug ID |
D09VXM
|
| NDC Product Code |
66039-854; 70564-802 |
| UNII |
PY79D6C8RX
|
| Synonyms |
crofelemer | Fulyzaq |
|
| Chemical Information |
| Molecular Formula |
C63H98N18O13S |
| CAS Registry Number |
33507-63-0 |
| SMILES |
CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(
=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCC
N=C(N)N)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
